DXRAY, INC.
Medtech · Private
Photon-counting energy-dispersive x-ray detector arrays for breast imaging with scanning slit digital mammography and tomosynthesis
- Grants
- $2.1M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $378K
- 2 awards · NASA
- #405 of 4531 in medtech
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200820092010201120122013201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | National Aeronautics and Space Administration · Build And Test A Mercuric-iodide Anticoincidence Shield To Significantly Improved Gamma-ray Spectroscopy In Planetary Missions. | $277,835 | |
| Federal contract | National Aeronautics and Space Administration · We Propose To Utilize Guard Ring Electrode Structures And A New Film Growth Technique To Create Improved Polycrystalline Mercuric Iodide Detectors For Background Suppression By Active Anticoincidence Shielding In Gamma-ray Spectrometers. Two Proposed NASA Missions Will Require Anticoincidence Shielding For X-ray And Gamma-ray Spectrometers: The High Energy Telescope Of The Exist (energetic X-ray Imaging Survey Telescope) Mission, And The Space Science Vision Mission Expected To Visit Titan, One | $99,984 | |
| Federal grant | Department of Energy · Phase II · Efficient Large-area X-ray Detectors | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Low Dose Rapid Scanning Slit Digital Mammography and Breast Tomosynthesis | $680,133 | |
| Federal grant | Department of Health and Human Services · Phase II · Low Dose Rapid Scanning Slit Digital Mammography and Breast Tomosynthesis | $460,000 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 402 | INSO BIOSCIENCES INC | $400K | $2.5M |
| 403 | VOXIMETRY INC | $397K | $4.6M |
| 404 | Opko Health, Inc. | $387K | $206M |
| 405 | DXRAY, INC. | $378K | — |
| 406 | RESHAPE LIFESCIENCES INC | $374K | $114M |
| 407 | CELLFE INC | $359K | — |
| 408 | CAPTIS DIAGNOSTICS | $355K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Pixelated Cadmium Zinc Telluride Based Photon Counting Mode Detectorapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.